| abstract |
The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and 5 diabetes. In particular embodiments, the structure of the compounds is given by Formula (I), wherein Q, R , X , X2, Y and R2 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same. |